PATENT CLAIM ANALYSIS

Application Number: 16033038
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["544", "236000"]

Abstract:
The present invention provides protein kinase having one of the following structures (I), (II) or (III): or a stereoisomer, prodrug, tautomer or pharmaceutically acceptable salt thereof, wherein R, R 1 , R 2  and X are as defined herein. Compositions and methods for using the same in the treatment of cancer, autoimmune, inflammatory and other Pim kinase-associated conditions are also disclosed.

Claim (Index 65):
A method for treating an autoimmune disorder, the method comprising:\n administering a therapeutically effective amount of a compound having the following structure: or a prodrug or pharmaceutically acceptable salt thereof, to a subject in need thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 95.0
- Lexical Diversity: 1.4
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15207224', '14795123', '15353312', '15017394', '15373923']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7755938996756688
- 35 USC 102 Novelty (BERT): 0.5429710388088237
- Combined Prediction Score: 0.7523316135889844
- Mean Citation Score: 313.8797800000001
- Max Citation Score: 392.47394
- Similarity Product: 283.5393193924987

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test